Researchers are investigating new biomarkers such as interleukin-6 (IL-6) and soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) for their potential as diagnostic and prognostic indicators in sepsis, offering hope for improved early detection and outcomes in adult populations. The gene discussed is IL6; the disease is Sepsis.